Ramana Uppoor

CONFLICT OF INTEREST The authors declared no competing interests for this work. Supporting Information Filename Description cpt70108-sup-0001-TableS1.docxWord 2007 document , 34.1 KB Table S1. cpt70108-sup-0002-TableS2.docxWord 2007 document , 24.3 KB Table S2. References 1 et al. Transforming drug development for neurological disorders: proceedings from a multidisease area workshop. Neurotherapeutics 20, 1682–1691 (2023). 2 et al. What evidence do we need for biomarker qualification? Sci. Transl. Med.

Shamir N Kalaria,Tiffany R Farchione,Ramana Uppoor,Mehul Mehta,Yaning Wang,Hao Zhu Shamir N Kalaria Division of Psychiatry, Office of New Drugs, Center for Drug Evaluation Research, White Oak, US Food and Drug Administration, Silver Spring, Maryland, USA. Tiffany R Farchione Division of Psychiatry, Office of New Drugs, Center for Drug Evaluation Research, White Oak, US Food and Drug Administration, Silver Spring, Maryland, USA.